Stay updated on FG-3019 Combination in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Combination in Pancreatic Cancer Clinical Trial page.

Latest updates to the FG-3019 Combination in Pancreatic Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and updated operating status. The page revision moved from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check10 days agoChange DetectedUI and metadata updates include adding a 'Show glossary' option, the 'Last Update Submitted that Met QC Criteria' label, capitalization tweaks for 'FEAR Act' data, and a revision tag 'Revision: v3.4.0' replacing v3.3.4, which do not affect trial data or study results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoChange DetectedKyntra Bio was added as sponsor and FibroGen was removed from the sponsor listing.SummaryDifference0.2%

- Check24 days agoChange DetectedA minor system revision (Revision: v3.3.4) was applied; no study details, eligibility criteria, or actions for participants were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedLocations section updated: new study sites in California, New Hampshire, Ohio, Oregon, Pennsylvania, and Washington were added, while prior location entries were removed. The page revision updated to v3.3.3.SummaryDifference0.8%

- Check75 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to FG-3019 Combination in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Combination in Pancreatic Cancer Clinical Trial page.